Edap Tms SA
EDAP
查看详细走势图
4.730USD
+0.730+18.25%
收盘 02/06, 16:00（美东）报价延迟15分钟
176.86M总市值
亏损市盈率 TTM
盘中分时
1分
30分
1小时
日k
周k
月k
日k
今天
+18.25%
5天
+12.62%
1月
+25.46%
6月
+278.40%
今年开始到现在
+43.77%
1年
+90.73%
查看详细走势图
TradingKey Edap Tms SA股票评分
单位: USD 更新时间: 2026-02-06操作建议
Edap Tms SA当前公司基本面数据相对健康，最新ESG披露属于行业领先水平。增长潜力很大。当前估值合理，在医疗设备与耗材行业排名95/205位。机构持股占比非常高，近一月多位分析师给出公司评级为持有。最高目标价6.83。中期看，股价处于上升通道。近一个月，市场表现很强，技术面和基本面综合得分较高，很强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间，可以做区间波段操作。
Edap Tms SA评分
压力支撑
由于公司未披露，未能获取相关数据
多维评测
本期评分
上期评分
公司舆情
过去24小时
热度
过冷
过热
中性
Edap Tms SA亮点
亮点风险
Edap Tms SA is a France-based company that develops, manufactures, promotes and distributes minimally invasive medical devices for urology based upon ultrasound technology. The Company's activity is organized in two divisions: HIFU (High Intensity Focused Ultrasound) and ESWL (Extracorporeal ShockWave Lithotripsy) that invests in research and development, partnering with INSERM French public laboratory and international medical research institutions. It specialises in HIFU technology, a non-invasive treatment of prostate conditions with a range of Robotic HIFU devices, Ablatherm Fusion and Focal One, ESWL and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications. It also operates worldwide via a network of corporate offices, subsidiaries and distribution partners
业绩高增长
公司营业收入稳步增长，连续3年增长17.42%
业绩增长期
公司处于发展阶段，最新年度总收入59.36M美元
利润高增长
公司净利润处于行业前列，最新年度总收入59.36M美元
估值合理
公司最新PE估值-10.61，处于3年历史合理位
活跃度增加
近期活跃度增加，过去20天平均换手率0.37
分析师目标
根据
3
位分析师
持有
评级
6.833
目标均价
+70.83%
涨幅空间
数据免责声明：分析师评级与目标价由LSEG提供，仅供参考，不应当作投资建议
Edap Tms SA新闻
即将为您带来更多新闻，敬请期待。。。
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
Edap Tms SA简介
Edap Tms SA is a France-based company that develops, manufactures, promotes and distributes minimally invasive medical devices for urology based upon ultrasound technology. The Company's activity is organized in two divisions: HIFU (High Intensity Focused Ultrasound) and ESWL (Extracorporeal ShockWave Lithotripsy) that invests in research and development, partnering with INSERM French public laboratory and international medical research institutions. It specialises in HIFU technology, a non-invasive treatment of prostate conditions with a range of Robotic HIFU devices, Ablatherm Fusion and Focal One, ESWL and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications. It also operates worldwide via a network of corporate offices, subsidiaries and distribution partners
公司代码EDAP
公司Edap Tms SA
CEORhodes (Ryan)
网址https://focalone.com/fr/accueil/
相关品种
+3.02%
+0.09%
+1.60%
+2.48%
+0.40%
-1.14%
-0.05%
-2.35%
-1.76%
+2.65%
+2.64%
+2.03%
+2.01%
+2.38%
+1.70%
+0.16%
+0.78%
+1.72%
+0.59%
-2.02%
